Alzheimer's disease (AD) is a progressive degenerative disease of the brain from which there is no recovery. The disease slowly attacks nerve cells in all parts of the cortex of the brain and some surrounding structures, thereby impairing a person's abilities to govern emotions, recognize errors and patterns, coordinate movement, and remember. Ultimately, a person with AD loses memory and many other mental functions.
Although Xyrem (sodium oxybate) failed to gain FDA approval for the treatment of fibromyalgia, it is sometimes prescribed off-label to... Read more »
On September 11, the FDA, Genentech and Biogen Idec (the manufacturers of Rituxan) announced that the labeling for the drug is being... Read more »